Mr. Chair, I'm happy to take that question.
This, I think, comes back to the fact that BlueDot is an infectious disease insights organization. The work we're doing with mobile data is just one small piece in what we do.
What we have developed is a platform that is monitoring online publicly available sources, currently in 65 different languages, using things like machine learning to help pick up early signals or clues that there may be an outbreak occurring in a particular area of the world maybe before it's actually officially reported. That is something we have developed over years, because ultimately we know that time is everything when you're trying to respond to an outbreak.
Our platform detected it back in late December of 2019, and, as I mentioned in my opening remarks, knowing that there's an outbreak is one thing, but actually understanding its potential for global spread is another. That's something that we also do, using the data on the worldwide movements of flights through the global airline transportation network that we all live in. We in fact published the world's first peer-reviewed study accurately predicting where COVID-19 would start to spread. That was back in early January of 2020.
I think this gives you a sense, hopefully, that as an organization we are looking at this problem holistically, from early detection to assessment and to emergency response.